atai Life Sciences (ATAI) Misses Q3 EPS by 17c

atai Life Sciences (NASDAQ: ATAI) reported Q3 EPS of ($0.28), $0.17 worse than the analyst estimate of ($0.11). Revenue for the quarter came in at $750 thousand.

For earnings history and earnings-related data on atai Life Sciences (ATAI) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Lockheed Martin wins $8.4B missile contract modification
• KB Home (KBH) Misses Q2 EPS by 2c; Offers Outlook